香港股市 已收市

BNTX Jul 2024 80.000 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
5.80+2.29 (+65.24%)
收市:10:20AM EDT
全螢幕
前收市價3.51
開市6.50
買盤4.90
賣出價5.70
拍板80.00
到期日2024-07-19
今日波幅5.60 - 7.00
合同範圍
成交量11
未平倉合約110
  • InvestorPlace

    3 Nasdaq Stocks to Sell in July Before They Crash & Burn

    When deciding which stocks to invest in, understanding which exchanges they are listed on can make a big difference in long-term performance and perception. For most U.S.-based investors, the two exchanges they hear about the most are the New York Stock Exchange (NYSE) and the Nasdaq. The NYSE is known for its relative stability and historically blue-chip stocks. On the other hand, the Nasdaq is a staple of high-growth and more speculative ventures like information technology, biotechnology and

  • Zacks

    Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod

    Pfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal Products for Human Use's positive opinion recommending marketing authorization.

  • Benzinga

    Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment

    AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a treatment forpatients suffering from specific type of endometrial cancer. Its pharma peer, BioNTech SE (NASDAQ: BNTX) wasn’t as lucky as also on Monday, the FDA put its experimental cancer drug study on partial clinical hold. Combining Immunotherapy And Chemotherapy Is Emerging As A New Standard In Ca